Article Text

Download PDFPDF
Person-centred care and HIV: challenges and solutions
  1. Tristan J Barber1,2,
  2. John Michael Saunders3,
  3. Nina Barnett4,5
  1. 1 St Stephen’s Centre, Chelsea and Westminster Hospital NHS Foundation Trust, London, UK
  2. 2 Faculty of Medicine, Imperial College London, London, UK
  3. 3 Centre for Clinical Research in Infection and Sexual Health, Institute for Global Health, University College London, London, UK
  4. 4 Pharmacy Department, London North West University Healthcare NHS Trust, London, UK
  5. 5 Medicines Use and Safety Team, NHS Specialist Pharmacy Service, Worthing, UK
  1. Correspondence to Dr John Michael Saunders, Centre for Clinical Research in Infection and Sexual Health, Institute for Global Health, University College London, London WC1E 6BT, UK; john.saunders{at}


Person-centred consultations (PCCs) are fundamental to effective healthcare communication, and its use is embedded within key clinical guidance. There are three aspects to PCC: use of the best available research evidence, clinical expertise of the clinician and the patient’s circumstances, goals, values and wishes. Balancing theses three aspects in the context of HIV prevention and management can be challenging, and we use three case examples to highlight these.

  • HIV clinical care
  • prevention
  • communication skills

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • Handling editor Sarah K Edwards

  • Contributors TB, JS and NB were involved at all stages of the manuscript (initial ideas, drafting and finalising the manuscript).

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests Dr Barber has received speakers honoraria, conference support, and advisory board fees from Gilead, Janssen, MSD, Roche, and ViiV in the last 12 months. Professor Barnett has received fees for lectures, webinars, writing, and speaking at learning events from Gilead, Celesio, Pfizer, Napp, Roche, in the last 12 months.

  • Patient consent Not required.

  • Provenance and peer review Commissioned; externally peer reviewed.